Get the Daily Brief
Latest Biotech News
DeepMind Unveils AlphaGenome: AI Predicts Gene Regulation from DNA Sequence
DeepMind has launched AlphaGenome, an advanced AI model that predicts the molecular effects of DNA sequence variants, offering unprecedented insights into gene regulation. By unifying multiple...
FDA Opens Investigation Into Sarepta's Duchenne Gene Therapy Post Patient Deaths
The FDA is actively investigating Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy Elevidys following two patient deaths linked to acute liver failure. The agency is evaluating...
Kymera Therapeutics Secures $750M Deal with Gilead Amid Sanofi Partner Shift
Kymera Therapeutics announced a significant collaboration with Gilead Sciences to develop molecular glue degraders targeting CDK2 in solid tumors, including breast cancer. The deal potentially...
City of Hope Launches HopeLLM: Generative AI Platform to Enhance Cancer Care
City of Hope has developed HopeLLM, a novel generative AI platform integrating multiple AI models to streamline patient onboarding, personalize clinical trial matching, and extract real-world data...
Breakthrough in Mitochondrial Base Editing Offers Hope for Genetic Disease Treatment
Researchers at the University Medical Center Utrecht have successfully utilized mitochondrial base editing (mtBE) to correct pathogenic mitochondrial DNA mutations in patient-derived cell models....
Adaptive Biotechnologies Surges After NCCN Updates Multiple Myeloma Guidelines
Adaptive Biotechnologies’ shares rose over 10% following the National Comprehensive Cancer Network’s updated multiple myeloma guidelines recommending baseline clonotype identification at diagnosis...
Innovative Therapy Converts Immune-Cold Glioblastoma Into Treatable Battlefield
Virginia Commonwealth University and Institute of Molecular Medicine researchers developed a fusion molecule combining IL-24S and IL-15 cytokines to target glioblastoma’s immunosuppressive...
PromoterAI: Deep Learning Model Identifies Disease-Causing Promoter Mutations
Illumina’s AI lab developed PromoterAI, a deep neural network that predicts deleterious mutations in gene promoters disrupting normal gene expression. By training on DNA sequence features...
Novel Molecular Glue Degrader Programs Propel Cancer Drug Development
Targeted protein degradation gains momentum as Kymera Therapeutics expands partnerships and clinical candidates. The company’s collaboration with Sanofi pivots to advancing a new IRAK4 degrader...
FDA and NIH Publish Unified Real-World Evidence Glossary to Standardize Research
The FDA and NIH jointly released the Modernizing Research and Evidence (MoRE) Consensus Definitions draft glossary to harmonize terminology in clinical and real-world evidence (RWE) research....
Generative AI Enhances Cancer Care at City of Hope
City of Hope has introduced a novel generative AI platform, HopeLLM, that leverages extensive oncology data and advanced models to streamline patient onboarding, personalize clinical trial...
Kymera Therapeutics Targets CDK2 in Cancer With New Partnerships
Kymera Therapeutics has signed a deal with Gilead Sciences to develop molecular glue degraders targeting cyclin-dependent kinase 2 (CDK2) for solid tumors including breast cancer, potentially...
FDA Investigates Sarepta’s Duchenne Gene Therapy After Patient Deaths
The FDA is reviewing safety concerns related to Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy following two patient deaths attributed to acute liver failure. Both...
Breakthroughs in Mitochondrial DNA Base Editing for Disease Models
Researchers from University Medical Center Utrecht and collaborators have successfully applied mitochondrial base editing to correct pathogenic mitochondrial DNA mutations in patient-derived human...
Advances in AI for Drug Discovery and Genomics
Gero introduced ProtoBind-Diff, a structure-free diffusion language model that designs drug-like molecules guided solely by protein amino acid sequences. Trained on over a million protein-ligand...
Immunotherapy Insights in Brain and Tumor Microenvironments
Studies reveal critical immune mechanisms influencing cancers in the central nervous system and glioblastoma. Hernandez-Barranco and Joyce identified interferon-gamma-activated dendritic cells...
Precision Diagnostics and Clinical Guidelines Impacting Cancer Care
Adaptive Biotechnologies’ stock rose following new NCCN multiple myeloma guidelines recommending baseline clonotype identification or aspirate storage at diagnosis to facilitate minimal residual...
Innovations in Renewable Energy and Environmental Technologies
Researchers have advanced perovskite solar cells optimized for indoor fluorescent light, enabling efficient electrical power generation in artificial lighting conditions. Another team developed a...
AI and Machine Learning Streamline Cell Therapy and Medical Device Testing
Cutting-edge approaches integrate machine learning with UV absorbance spectroscopy to rapidly detect microbial contamination in cell therapies within 30 minutes, enhancing sterility assurance...
Human ENS Cell Transplants Restore Gut Motility in Mice
Researchers have demonstrated the successful transplantation of human pluripotent stem cell (hPSC)-derived nitrergic neurons into the colonic wall of immunocompromised mice deficient in nitric...